Merck, Rigaku to form molecular structure analysis technology collab
The technology will determine the absolute chemical structure of organic molecules and enables X-ray crystallography without crystallisation of the analyte.
Read More
Tag: Rigaku
- UCB reports superiority of bimekizumab in psoriatic arthritis study
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
